SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 251 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $2,223,000 | -81.7% | 14,225 | -85.6% | 0.01% | -81.8% |
| Q2 2014 | $12,155,000 | -60.5% | 98,543 | -66.9% | 0.06% | -66.7% |
| Q1 2014 | $30,802,000 | +398.9% | 297,286 | +333.1% | 0.16% | +385.3% |
| Q4 2013 | $6,174,000 | -74.1% | 68,642 | -81.0% | 0.03% | -79.6% |
| Q2 2013 | $23,873,000 | – | 360,885 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $46,872,000 | 24.29% |
| HealthCor Management, L.P. | 935,100 | $146,100,000 | 7.50% |
| 1492 Capital Management LLC | 70,167 | $10,963,000 | 6.07% |
| Visium Asset Management, LP | 2,301,629 | $359,607,000 | 5.31% |
| HWG Holdings LP | 39,621 | $6,190,000 | 4.97% |
| Riggs Asset Managment Co. Inc. | 45,649 | $7,132,000 | 4.14% |
| Cardinal Capital Management | 49,139 | $7,677,000 | 3.65% |
| AMI ASSET MANAGEMENT CORP | 213,398 | $33,341,000 | 3.27% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 88,435 | $13,817,000 | 3.14% |
| Adamant Biomedical Investments AG | 78,210 | $12,220,000 | 3.05% |